Voie d'administration : Voie inhalée. Il conviendra d'informer le patient que pour observer un effet optimal du traitement, Seretide doit être administré quotidiennement même lorsque les symptômes ...
Le Seretide® est un médicament antiasthmatique produit par le laboratoire GlaxoSmithKline depuis 2000. Deux versions existent : Seretide® et Seretide Diskus®. Ces traitements se présentent sous forme ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates, clinicians may ...
Results of the European INSPIRE (Investigating New Standards for Prophylaxis in Reduction of Exacerbations) study, published in the American Journal of Respiratory and Critical Care Medicine (2008: ...
GlaxoSmithKline has received approval in Japan for its key respiratory product Seretide/Advair Diskus and its anti-thrombotic Arixtra, a move which the company says should make a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback